Literature DB >> 3136149

Cell culture studies on patients with mitochondrial diseases: molecular defects in pyruvate dehydrogenase.

B H Robinson1.   

Abstract

There is a group of inborn errors of metabolism that result in the condition of chronic lacticacidemia of childhood. Nearly all of the defects that can be identified occur in mitochondrial proteins, and can be demonstrated in cultured skin fibroblasts from the patients concerned. One approach to the diagnosis of these defects involves a simple incubation of the fibroblast culture with glucose-containing medium followed by the measurement of accumulated lactate and pyruvate. The total amounts of lactate and pyruvate and the ratio between them is different in cells from patients with defects in the pyruvate dehydrogenase complex or the respiratory chain. Measurement of 1-14C-pyruvate oxidation to 14CO2 can also reveal defective oxidative metabolism. Localization of the defects can be achieved using individual assays for the enzymes concerned. The clinical sequelae of the different defects is discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3136149     DOI: 10.1007/bf00769635

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  33 in total

1.  Deficiency of the pyruvate dehydrogenase component in pyruvate dehydrogenase complex-deficient human fibroblasts. Immunological identification.

Authors:  L Ho; C W Hu; S Packman; M S Patel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

2.  Kinetic properties of human F4 phosphofructokinase: a poor regulatory enzyme.

Authors:  M C Meienhofer; D Cottreau; J C Dreyfus; A Kahn
Journal:  FEBS Lett       Date:  1980-02-11       Impact factor: 4.124

Review 3.  Pyridine nucleotides and rate control.

Authors:  H A Krebs
Journal:  Symp Soc Exp Biol       Date:  1973

4.  Regulation of mammalian pyruvate dehydrogenase complex by a phosphorylation-dephosphorylation cycle.

Authors:  L J Reed
Journal:  Curr Top Cell Regul       Date:  1981

5.  Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex.

Authors:  B H Robinson; H MacMillan; R Petrova-Benedict; W G Sherwood
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

6.  The human pyruvate dehydrogenase complex. Isolation of cDNA clones for the E1 alpha subunit, sequence analysis, and characterization of the mRNA.

Authors:  H H Dahl; S M Hunt; W M Hutchison; G K Brown
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

7.  The French and North American phenotypes of pyruvate carboxylase deficiency, correlation with biotin containing protein by 3H-biotin incorporation, 35S-streptavidin labeling, and Northern blotting with a cloned cDNA probe.

Authors:  B H Robinson; J Oei; J M Saudubray; C Marsac; K Bartlett; F Quan; R Gravel
Journal:  Am J Hum Genet       Date:  1987-01       Impact factor: 11.025

8.  Defective intramitochondrial NADH oxidation in skin fibroblasts from an infant with fatal neonatal lacticacidemia.

Authors:  B H Robinson; N McKay; P Goodyer; G Lancaster
Journal:  Am J Hum Genet       Date:  1985-09       Impact factor: 11.025

9.  Immunoextraction of lipoamide dehydrogenase from cultured skin fibroblasts in patients with combined alpha-ketoacid dehydrogenase deficiency.

Authors:  G Otulakowski; W Nyhan; L Sweetman; B H Robinson
Journal:  Clin Chim Acta       Date:  1985-10-31       Impact factor: 3.786

10.  Glucose transport and metabolism in cultured human skin fibroblasts.

Authors:  N D McKay; B Robinson; R Brodie; N Rooke-Allen
Journal:  Biochim Biophys Acta       Date:  1983-04-05
View more
  6 in total

1.  Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency.

Authors:  T Bourgeron; D Chretien; J Poggi-Bach; S Doonan; D Rabier; P Letouzé; A Munnich; A Rötig; P Landrieu; P Rustin
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

2.  Investigation of enzyme defects in children with lactic acidosis.

Authors:  B Merinero; C Pérez-Cerda; M Ugarte
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome.

Authors:  M E Vazquez-Memije; S Shanske; F M Santorelli; P Kranz-Eble; E Davidson; D C DeVivo; S DiMauro
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  X-linked pyruvate dehydrogenase E1 alpha subunit deficiency in heterozygous females: variable manifestation of the same mutation.

Authors:  H H Dahl; L L Hansen; R M Brown; D M Danks; J G Rogers; G K Brown
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

5.  Cytoplasmic transfer of the mtDNA nt 8993 T-->G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio.

Authors:  I Trounce; S Neill; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

Review 6.  p66Shc aging protein in control of fibroblasts cell fate.

Authors:  Jan M Suski; Agnieszka Karkucinska-Wieckowska; Magdalena Lebiedzinska; Carlotta Giorgi; Joanna Szczepanowska; Gyorgy Szabadkai; Jerzy Duszynski; Maciej Pronicki; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int J Mol Sci       Date:  2011-08-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.